• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Puma Biotechnology Inc - Common Stock (NQ:PBYI)

    8.085 +0.415 (+5.41%)
    Streaming Delayed Price Updated: 10:48 AM EDT, Jun 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 29,999
    Open 7.670
    Bid (Size) 8.070 (200)
    Ask (Size) 8.100 (100)
    Prev. Close 7.670
    Today's Range 7.670 - 8.090
    52wk Range 3.030 - 8.410
    Shares Outstanding 47,509,765
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma (PBYI) Q1 2026 Earnings Call Transcript ↗
    Puma (PBYI) Q1 2026 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    +40.1%
    +40.1%
    1 Month
    +11.2%
    +11.2%
    3 Month
    +28.9%
    +28.9%
    6 Month
    +31.3%
    +31.3%
    1 Year
    +144.3%
    +144.3%

    More News

    Read More
    News headline image
    Puma Biotechnology Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) Beats Q1 Estimates, Raises Full-Year Guidance ↗
    Via Chartmill
    Puma Biotechnology (NASDAQ:PBYI) Beats Q4 Estimates, Guides for Profitable 2026 ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Puma Biotechnology Reports First Quarter 2026 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? ↗
    Via The Motley Fool
    News headline image
    Puma Biotech (PBYI) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology (NASDAQ:PBYI) Tops Q3 2025 Estimates and Raises Full-Year Outlook ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Puma Biotechnology Reports Third Quarter 2025 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    News headline image
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Puma Biotechnology Inc - Common Stock publicly traded?
    Yes, Puma Biotechnology Inc - Common Stock is publicly traded.
    What exchange does Puma Biotechnology Inc - Common Stock trade on?
    Puma Biotechnology Inc - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Puma Biotechnology Inc - Common Stock?
    The ticker symbol for Puma Biotechnology Inc - Common Stock is PBYI on the Nasdaq Stock Market
    What is the current price of Puma Biotechnology Inc - Common Stock?
    The current price of Puma Biotechnology Inc - Common Stock is 8.085
    When was Puma Biotechnology Inc - Common Stock last traded?
    The last trade of Puma Biotechnology Inc - Common Stock was at 06/26/26 10:48 AM ET
    What is the market capitalization of Puma Biotechnology Inc - Common Stock?
    The market capitalization of Puma Biotechnology Inc - Common Stock is 384.12M
    How many shares of Puma Biotechnology Inc - Common Stock are outstanding?
    Puma Biotechnology Inc - Common Stock has 384M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.